Novateur Ventures explores new strategy to reduce hyperinflammatory response caused by COVID-19 Read more
Hilleman Labs is developing a liquid form of meningococcal vaccine in a single container closure Read more
Pankajakasthuri declares final clinical trials of ZingiVir-H as adjunct therapy for COVID-19 patients Read more
AbbVie, Amgen and Takeda jointly study impact of anti-inflammatory drugs in COVID-19 treatment Read more